Parkside Financial Bank & Trust Bio Rad Laboratories, Inc. Transaction History
Parkside Financial Bank & Trust
- $742 Million
- Q4 2024
A detailed history of Parkside Financial Bank & Trust transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 16 shares of BIO stock, worth $5,233. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 21
23.81%
Holding current value
$5,233
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding BIO
# of Institutions
466Shares Held
18.7MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.92MShares$628 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$507 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$341 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$319 Million3.36% of portfolio
-
Van Eck Associates Corp723KShares$237 Million0.3% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.06B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...